Abstract:Optically pure calcium (R)-pantothenate has been obtained from the racemic compound via direct fractional crystallization of the single enantiomer. Efficient racemization of the biologically inactive calcium (S)-pantothenate without its decomposition to pantolactone has been developed, resulting in a simple, complete, and efficient technology. The results elaborated in the laboratory have been then successfully applied in the industrial scale process.
“…Also very recently, the advantages of preferential crystallization were proven for resolving racemic calcium pantothenate (with the (R)-enantiomer an important commercial precursor of vitamin B 5 ) and an industrially required resolving agent, both in lab and technical scale (35 L and 35 L) reaching high yields. [96,97] Detailed information on preferential crystallization can be found in several overview articles [e.g. 94,98] and book contributions.…”
Section: Preferential Crystallization Of Conglomeratesmentioning
The provision of pure enantiomers is of increasing importance not only for the pharmaceutical industry but also for agrochemistry and biotechnology. In general, there are two rival approaches to provide pure enantiomers. The "chiral" approach is based on developing an asymmetric synthesis of just one of the enantiomers, while the "racemic" approach is based on separating mixtures of the two enantiomers. In the last few years remarkable progress has been achieved in the latter area. This Review focuses in particular on enantioselective crystallization processes and preparative chromatography, including hybrid processes and the incorporation of racemization steps. Several examples from our research are used for illustration purposes.
“…Also very recently, the advantages of preferential crystallization were proven for resolving racemic calcium pantothenate (with the (R)-enantiomer an important commercial precursor of vitamin B 5 ) and an industrially required resolving agent, both in lab and technical scale (35 L and 35 L) reaching high yields. [96,97] Detailed information on preferential crystallization can be found in several overview articles [e.g. 94,98] and book contributions.…”
Section: Preferential Crystallization Of Conglomeratesmentioning
The provision of pure enantiomers is of increasing importance not only for the pharmaceutical industry but also for agrochemistry and biotechnology. In general, there are two rival approaches to provide pure enantiomers. The "chiral" approach is based on developing an asymmetric synthesis of just one of the enantiomers, while the "racemic" approach is based on separating mixtures of the two enantiomers. In the last few years remarkable progress has been achieved in the latter area. This Review focuses in particular on enantioselective crystallization processes and preparative chromatography, including hybrid processes and the incorporation of racemization steps. Several examples from our research are used for illustration purposes.
“…Apparently, methyldopa 35 should be considered as the first example of this kind, because its pure ( S )‐enantiomer has been produced industrially via direct resolution of the racemic product . Spontaneous resolution is a property exhibited by albuterol sulfate 36 and calcium pantothenate 37 .…”
Section: Using Direct Methods To Obtain Single Enantiomer Apismentioning
In the 21st century, single enantiomeric chiral active pharmaceutical ingredients (APIs) prevail among new drugs. Their preparation is made easier by using direct methods for the separation of racemates. The history of this issue is summarized and information about new and updated methods of conglomerate identification and practical implementation options for direct resolutions is provided. Examples are given for the application of direct methods for obtaining enantiopure APIs by the resolution of their racemic synthetic precursors, using a slight modification of the target product and finally by direct resolution of the racemic chiral drugs as such.
“…Darin werden insbesondere die Anwendung von Fließbettkristallisatoren und die kontinuierliche In‐situ‐Generierung von Impfkristallen zur Aufrechterhaltung des Prozessregimes hervorgehoben. Ebenfalls erst kürzlich konnte der erfolgreiche Einsatz der Bevorzugten Kristallisation für die Spaltung von racemischem Calciumpantothenat (dessen ( R )‐Enantiomer eine bedeutende kommerzielle Vorstufe von Vitamin B 5 ist) und eines industriell wichtigen Trennreagens gezeigt werden, wobei für beide sowohl im Labor‐ als auch im technischen (3000 L und 35 L) Maßstab hohe Ausbeuten erreicht wurden 96. 97…”
Section: Kristallisationsbasierte Methoden Zur Enantiomerentrennungunclassified
Die Verfügbarkeit reiner Enantiomere ist von steigender Bedeutung für die pharmazeutische Industrie sowie auch für die Agrochemie und Biotechnologie. Generell gibt es zwei konkurrierende Ansätze zur Gewinnung von reinen Enantiomeren. Der “chirale” Ansatz basiert auf der Entwicklung einer asymmetrischen Synthese, die selektiv eines der Enantiomere liefert. Der “racemische” Ansatz basiert auf der Trennung eines Gemischs der beiden Enantiomere, wobei hier in den letzten Jahren bemerkenswerte Fortschritte erzielt werden konnten. Dieser Aufsatz fokussiert insbesondere auf enantioselektive Kristallisationsprozesse und präparative Chromatographie, einschließlich hybrider Trennprozesse und der zusätzlichen Integration von Racemisierungsschritten. Zur Illustration dienen mehrere in unserem Arbeitskreis untersuchte Trennungen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.